Table 5.
0–48 h | 48 h–1 week | >1 week | |
---|---|---|---|
Aspergillusgalactomannan | 3/8 | 4/8 | 1/8 |
β-D-glucan | 3/8 | 4/8 | 1/8 |
mannan | 2/6 * | 3/6 * | 1/6 * |
anti-mannan | 2/5 * | 2/5 * | 1/5 * |
antibodies against Aspergillus | 4/5 * | 1/5 * | |
Cryptococcus antigen (agglutination) | 2/6 * | 4/6 * | |
Cryptococcus antigen (lateral flow) | 2/5 * | 3/5 * | |
IFA for Pneumocystis jirovecii | 2/6 * | 4/6 * | |
Aspergillus PCR | 2/8 | 6/8 | |
Candida PCR | 2/8 | 6/8 | |
Cryptococcus PCR | 2/6 * | 4/6 * | |
Pneumocystis PCR | 1/7 * | 6/7 * |
* Answers about the non-culture-based methods’ turnaround time were not available for the total of the Units. IFA: Immunofluorescence Assay.